基本信息
views: 5
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Immunoregulation of autoimmune and infectious diseases. My research program as Canada Research Chair in Regulatory lymphocytes of the Immune System focuses on the immune regulation of autoimmune and infectious diseases mediated by naturally-occurring CD4+ regulatory T cells (nTreg), a unique population of cells with potent immunosuppressive functions in vitro an in vivo. nTreg cells constitute 1-10% of total CD4+ T cells from thymus, peripheral blood and lymphoid tissues in mice and humans. Functional abrogation of these cells in the host results in the onset of multi-organ-specific autoimmune diseases, and increases immunity to tumors, grafts, and various pathogens. Thus, nTreg cells play a central role in dampening peripheral immune responses, and contribute to the establishment of tolerance by an as-of-yet undefined mechanism.
My laboratory makes use of cutting-edge experimental strategies to characterize the relative contribution of nTreg cells as a determining factor in establishing resistance or susceptibility to autoimmune and infectious diseases. We try to characterize the functional dynamics of nTreg cell activity in human autoimmune diseases (type 1 diabetes) as well as in animal models of autoimmunity (type 1 diabetes), tumors (spontaneous breast cancer), infections (malaria), and mucosal immunity (inflammatory bowel disease). My research program makes use of standard and state-of-the-art molecular, proteomic, biochemical, cellular and imaging approaches to characterize the behavior of nTreg cells in health and disease.
My laboratory makes use of cutting-edge experimental strategies to characterize the relative contribution of nTreg cells as a determining factor in establishing resistance or susceptibility to autoimmune and infectious diseases. We try to characterize the functional dynamics of nTreg cell activity in human autoimmune diseases (type 1 diabetes) as well as in animal models of autoimmunity (type 1 diabetes), tumors (spontaneous breast cancer), infections (malaria), and mucosal immunity (inflammatory bowel disease). My research program makes use of standard and state-of-the-art molecular, proteomic, biochemical, cellular and imaging approaches to characterize the behavior of nTreg cells in health and disease.
Research Interests
Papers共 219 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
CANCER BIOLOGY & THERAPYno. 1 (2024): 2365452-2365452
Miroslava Cuperlovic-Culf, Steffany A.L. Bennett,Yannick Galipeau,Pauline S. McCluskie,Corey Arnold, Salman Bagheri,Curtis L. Cooper,Marc-André Langlois,Jörg Fritz,Ciriaco A. Piccirillo,Angela M. Crawley
iSciencepp.110484, (2024)
Cancer Researchno. 6_Supplement (2024): 6641-6641
Mucosal Immunologyno. 2 (2024): 201-210
Frontiers in Immunology (2024)
JOURNAL OF CLINICAL INVESTIGATIONno. 9 (2024)
BRITISH JOURNAL OF PHARMACOLOGY (2024)
British journal of pharmacology (2024)
FRONTIERS IN IMMUNOLOGY (2024): 1331846-1331846
Load More
Author Statistics
#Papers: 220
#Citation: 17208
H-Index: 52
G-Index: 131
Sociability: 7
Diversity: 3
Activity: 49
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn